Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (801-810 of 850) with videos related to

Pageof 85
Sort By:
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Cancers|April 14, 2025
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in QuadragenariansFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Medical Image Analysis|November 27, 2025
A systematic analysis of the impact of data variation on AI-based histopathological grading of prostate cancerPatrick Fuhlert, Fabian Westhaeusser, Esther Dietrich, et al.
Urologic Oncology|September 6, 2025
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinomaNatali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Cancer Discovery|August 30, 2012
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylationStefan T Börno, Axel Fischer, Martin Kerick, et al.
European Urology Focus|March 11, 2023
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cmStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Robust, credible, and interpretable AI-based histopathological prostate cancer gradingFabian Westhaeusser, Patrick Fuhlert, Esther Dietrich, et al.
Pageof 85

Showing results (801-810 of 850) with videos related to

Sort By:
Pageof 85
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Cancers|April 14, 2025
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in QuadragenariansFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Medical Image Analysis|November 27, 2025
A systematic analysis of the impact of data variation on AI-based histopathological grading of prostate cancerPatrick Fuhlert, Fabian Westhaeusser, Esther Dietrich, et al.
Urologic Oncology|September 6, 2025
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinomaNatali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Cancer Discovery|August 30, 2012
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylationStefan T Börno, Axel Fischer, Martin Kerick, et al.
European Urology Focus|March 11, 2023
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cmStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Robust, credible, and interpretable AI-based histopathological prostate cancer gradingFabian Westhaeusser, Patrick Fuhlert, Esther Dietrich, et al.
Pageof 85